OBJECTIVE

To determine the impact of 20 weeks of exercise training in aerobic capacity on left ventricular function and glycemic control in adolescents with and without type 1 diabetes.

RESEARCH DESIGN AND METHODS

Fifty-three adolescents with type 1 diabetes (aged 15.6 years) were divided into two groups: exercise training (n = 38) and nontraining (n = 15). Twenty-two healthy adolescents without diabetes (aged 16.7 years) were included and, with the 38 participants with type 1 diabetes, participated in a 20-week exercise-training intervention. Assessments included VO2max and body composition. Left ventricular parameters were obtained at rest and during acute exercise using MRI.

RESULTS

Exercise training improved aerobic capacity (10%) and stroke volume (6%) in both trained groups, but the increase in the group with type 1 diabetes remained lower than trained control subjects. Increased stroke volume in adolescents with type 1 diabetes resulted from greater left ventricular contractility (9% increase in ejection fraction and an 11% reduction in end-systolic volumes) and, to a lesser extent, improved left ventricular filling (6%), suggesting that impaired diastolic function can be affected by exercise training in adolescents with type 1 diabetes. Insulin use decreased by ∼10%, but no change in glycemic status was observed.

CONCLUSIONS

These data demonstrate that in adolescents, the impairment in left ventricular function seen with type 1 diabetes can be improved, although not normalized, with regular intense physical activity. Importantly, diastolic dysfunction, a common mechanism causing heart failure in older subjects with diabetes, appears to be partially reversible in this age group.

Regular physical activity has many potential health benefits, and there is strong evidence of its role in the primary and secondary prevention of chronic diseases such as cardiovascular disease and diabetes (1). In particular, exercise training improves exercise capacity and cardiac output by increasing left ventricular function (25). Training increases left ventricular stroke volume by enhancing intrinsic cardiac contractility (decreased end-systolic volume and increased ejection fraction) and improving left ventricular filling (increased end-diastolic volume) (6,7).

Adults and adolescents with type 1 diabetes have reduced exercise capacity (810), which increases their risk for cardiovascular morbidity and mortality (11). The causes for this reduced exercise capacity are unclear. However, recent studies have shown that adolescents with type 1 diabetes have lower stroke volume during exercise, which has been attributed to alterations in left ventricular function (9,10). Reduced left ventricular compliance resulting in an inability to fill the left ventricle appropriately during exercise has been shown to contribute to the lower stroke volume during exercise in both adults and adolescents with type 1 diabetes (12).

Exercise training is recommended as part of the management of type 1 diabetes. However, the effects of exercise training on left ventricular function at rest and during exercise in adolescents with type 1 diabetes have not been investigated. In particular, it is unclear whether exercise training improves cardiac hemodynamics during exercise in adolescents with diabetes. Therefore, we aimed to assess left ventricular volumes at rest and during exercise in a group of adolescents with type 1 diabetes compared with adolescents without diabetes before and after a 20-week exercise-training program. We hypothesized that exercise training would improve exercise capacity and exercise stroke volume in adolescents with diabetes.

Study Participants

Baseline data comparing adolescents with type 1 diabetes and healthy control subjects have been previously published (10). This study reports the effects of 20 weeks of exercise training on the left ventricular function in this population. Adolescents with type 1 diabetes or healthy control subjects without diabetes aged 14–18 years and matched for sex, body composition, pubertal stage, and reported physical activity levels were recruited for this study. Participants with diabetes were sequentially recruited from the Auckland Adolescent Diabetes Clinic, whereas the control subjects were friends or siblings without diabetes with similar reported levels of physical activity. All participants were healthy with no evidence of hypertension, microvascular complications such as retinopathy, neuropathy, or microalbuminuria, and no chronic diseases other than type 1 diabetes. None of the adolescents with type 1 diabetes was taking regular medications other than insulin. This study was approved by the Northern X Regional Ethics Committee-Ministry of Health (reference number NTX/07/12/125) and registered at the Australian New Zealand Clinical Trials Registry (ACTRN12608000075381). All participants provided written informed consent, and it was compulsory for those under the age of 16 to have written parental consent to participate in the study.

Ninety adolescents with type 1 diabetes were eligible from the Auckland Adolescent Diabetes Clinic, of whom 53 (27 males) agreed to participate in our study. Twenty-seven healthy control subjects were contacted from the community (friends or family members of participants with diabetes), and 22 agreed to participate. Note that apart from examining between-group differences, we were also interested in assessing possible effects of exercise within the training group with type 1 diabetes, particularly in regards to associations with HbA1c. Thus, we adopted a 2:1 randomization strategy so that we would have approximately twice as many participants with diabetes training, which would increase the statistical power to detect within-group differences. Participant randomization was performed using an electronically generated random list allocating adolescents with type 1 diabetes to the exercise or nonexercise group. Because of timeline restrictions, recruitment was ceased once 75 participants were enrolled, thus the unbalanced group numbers. Consequently, 38 (20 male) participants with type 1 diabetes were then randomized to engage in a 20-week exercise program, whereas the remaining 15 acted as a nontraining control group. The 22 healthy control subjects (10 males) who were matched for sex, body composition, and reported physical activity levels also engaged in the 20 weeks of exercise training. All posttraining assessments were conducted between 5 and 7 days after the last exercise session. Note that all procedures were not carried out and therefore rescheduled if the participant's blood glucose levels were <5 or >12 mmol/L.

Body Composition

Body composition was determined by DXA (GE Lunar Prodigy, Madison, WI) using the standard manufacturer’s software (Encore v.4) as formerly described (10). BMI was calculated as weight in kilograms divided by height in meters squared. Abdominal adiposity was estimated by the ratio of android fat to gynoid fat, which was measured automatically by the Prodigy enCORE software. Antecubital venous blood samples were collected to determine HbA1c.

Functional Aerobic Capacity

Functional aerobic capacity was assessed by pedaling to exhaustion on an electronically braked cycle ergometer (Schiller, Baar, Switzerland) as previously described (TrueOne 2400 Metabolic Measurement System; Parvo Medics, Sandy, UT) (10).

Left Ventricular Function at Rest and During Exercise

Cardiac MRIs were obtained at rest and during acute exercise using a 1.5T Magnetom Avanto MRI scanner (Siemens, Erlangen, Germany) as previously described (10,13). Left ventricular exercise images were obtained once 1 min of steady-state heart rate (110 ± 5 bpm) was reached. Images were acquired during breath-hold maneuvers at midexpiration. Ergometer resistance and participants’ cycling speed (revolutions per minute) were adjusted to maintain the target heart rate of ±5 bpm. Blood pressure measurement was obtained after resting cardiac images were obtained and during pedaling, at the end of exercise measurements.

Analyses of cardiac MRI analyses were performed with the Cardiac Image Modeler software (University of Auckland, Auckland, New Zealand). Parameters obtained included ejection fraction, stroke volume, cardiac output, end-systolic volume, and end-diastolic volume. Stroke work was calculated by dividing stroke volume by mean arterial pressure. Total peripheral resistance was calculated by dividing mean arterial pressure by cardiac output. The O2 pulse was calculated by dividing oxygen consumption per heartbeat. The analyses of MRI data were performed blinded. However, data on maximal aerobic capacity analysis were not blinded, as the group with diabetes required blood glucose testing before and after the procedures, and data were collected by assessor. All assessments were performed by the same experienced exercise physiologist.

Exercise Training

Exercise training consisted of four 60-min (including warm-up and cool-down periods) exercise sessions per week over 20 weeks. Sessions were performed individually or with a friend, under the supervision of an exercise physiologist. Training was progressively adjusted to achieve 85% of the participant’s maximal heart rate (obtained during the VO2peak test) during aerobic exercise training (weeks 1–4). After that (weeks 5–20), participants were asked to exercise at the target heart rates of 85% of the maximal heart rate for a minimum of 40 min/session during the aerobic sessions. Participants were instructed to perform at least three sessions a week of aerobic training (combination of treadmill, cycling, and rowing machine with interval training) followed by weekly resistance training (weight training and core exercises) from weeks 1–12. From weeks 12–20, participants engaged in four exercise sessions a week of combined aerobic and resistance training (circuit training). This planned change in exercise regimen aimed at sustaining the participant's engagement with the program, so that compliance with the exercise protocol was maximized. Participants had up to 30-s rest (to catch their breath) between exercise/mode of exercise.

Each participant in the training group received a downloadable heart rate monitor (Polar S625X; Polar Electro, Kempele, Finland) that was used to record their exercise sessions. These records provided a quantitative assessment of compliance and ensured that participants were exercising at appropriate target heart rates. Data were downloaded into a research database using a Polar infrared device (Polar Electro, Hong Kong).

Data Analyses

Age and diabetes duration data were compared using one-way ANOVA and sex ratio with a χ2 test. All other study parameters were compared using linear regression models, controlling for age and sex. For specific cardiac parameters (ejection fraction, stroke volume, cardiac output, end-systolic volume, end-diastolic volume, stroke work, and total peripheral resistance), fat-free mass was also included as a covariate. Analyses were carried out in SAS version 9.3 (SAS Institute, Cary, NC). All statistical tests were two-tailed. Significance level was maintained at P < 0.05, with no adjustments for multiple comparisons. Age and diabetes duration data are reported as means ± SD; all other data are means and 95% CIs adjusted for confounders in the multivariate models.

From the 75 participants enrolled at baseline, 3 participants with type 1 diabetes (1 male and 2 female) did not complete the study (because of the time commitment required). The final study population consisted of 72 participants: 37 with type 1 diabetes in the exercise-training group; 13 with type 1 diabetes in the control group; and 22 adolescents without diabetes in the exercise-training group.

Participants’ Characteristics and Body Composition

Table 1 shows the participants’ characteristics before and after training. The training group without diabetes was ∼1 year older than the groups with type 1 diabetes at the start of the study. There were no other baseline differences between groups. After 20 weeks, both groups with type 1 diabetes significantly increased their total body weight. Interestingly, the control group with type 1 diabetes gained weight by accumulating fat, as seen by an increase in percentage body fat, whereas in the training group with type 1 diabetes, the increase in body weight was because of greater fat-free mass. Exercise training had a positive impact on body composition, with both training groups reducing their percentage body fat and increasing fat-free mass and bone mineral density. Exercise training did not modify HbA1c levels on the study groups, but it reduced daily insulin consumption by ∼10% in the training group with type 1 diabetes.

Table 1

Demography, clinical characteristics, and body composition at baseline and after 20 weeks (posttraining) in adolescents with type 1 diabetes who trained (T1D Tx), with type 1 diabetes who did not train (T1D Con), and without diabetes who trained (ND Tx)

Baseline
Posttraining
T1D ConT1D TxND TxT1D ConT1D TxND Tx
N (% female) 15 (53) 38 (47) 22 (55) 13 (46) 37 (49) 22 (55) 
Age (years) 15.5 ± 0.9* 15.6 ± 1.3* 16.7 ± 1.5 — — — 
Diabetes duration (years) 7.5 ± 4.0 5.4 ± 3.4 — — — — 
HbA1c (%) 8.57 (7.84–9.31)**** 8.80 (8.36–9.25)**** 5.15 (4.43–5.88) 8.67 (8.06–9.28)**** 8.50 (8.13–8.86)**** 5.14 (4.45–5.83) 
HbA1c (mmol/mol) 70 (62–78) 73 (68–78) 33 (25–41) 71 (65–78) 69 (65–73) 33 (25–40) 
Insulin (units/day) 73.8 (60.4–87.3) 64.8 (57.5–72.2) — 80.3 (64.5–96.1) 59.1 (50.3–67.9),# — 
Weight (kg) 69.2 (63.3–75.1) 69.8 (66.1–73.6) 64.6 (59.5–69.7) 71.0 (65.0–77.0)# 70.2 (66.6–73.8)# 65.7 (60.9–70.5) 
BMI (kg/m224.6 (22.8–26.4) 23.5 (22.4–24.7) 23.0 (21.4–24.5) 25.0 (23.1–26.9) 23.5 (22.4–24.7) 23.1 (21.5–24.6) 
Bone mineral density (g/cm21.184 (1.140–1.229) 1.141 (1.113–1.169) 1.136 (1.110–1.174) 1.181 (1.138–1.122) 1.146 (1.120–1.172)#### 1.154 (1.120–1.189)#### 
Percent fat-free mass 74.2 (70.0–78.3) 74.3 (71.7–76.9) 73.1 (69.5–76.6) 72.6 (68.0–77.1) 75.3 (72.6–78.1)#### 73.9 (70.3–77.6)## 
Percent total body fat 27.3 (23.0–31.6) 26.8 (24.0–29.5) 27.9 (24.2–31.6) 28.6 (24.0–33.2)# 25.7 (22.9–28.5)## 26.8 (23.0–30.5)## 
Android fat to gynoid fat ratio 0.884 (0.791–0.976) 0.855 (0.797–0.913) 0.827 (0.748–0.906) 0.897 (0.789–1.00) 0.841 (0.776–0.905) 0.844 (0.758–0.931) 
Baseline
Posttraining
T1D ConT1D TxND TxT1D ConT1D TxND Tx
N (% female) 15 (53) 38 (47) 22 (55) 13 (46) 37 (49) 22 (55) 
Age (years) 15.5 ± 0.9* 15.6 ± 1.3* 16.7 ± 1.5 — — — 
Diabetes duration (years) 7.5 ± 4.0 5.4 ± 3.4 — — — — 
HbA1c (%) 8.57 (7.84–9.31)**** 8.80 (8.36–9.25)**** 5.15 (4.43–5.88) 8.67 (8.06–9.28)**** 8.50 (8.13–8.86)**** 5.14 (4.45–5.83) 
HbA1c (mmol/mol) 70 (62–78) 73 (68–78) 33 (25–41) 71 (65–78) 69 (65–73) 33 (25–40) 
Insulin (units/day) 73.8 (60.4–87.3) 64.8 (57.5–72.2) — 80.3 (64.5–96.1) 59.1 (50.3–67.9),# — 
Weight (kg) 69.2 (63.3–75.1) 69.8 (66.1–73.6) 64.6 (59.5–69.7) 71.0 (65.0–77.0)# 70.2 (66.6–73.8)# 65.7 (60.9–70.5) 
BMI (kg/m224.6 (22.8–26.4) 23.5 (22.4–24.7) 23.0 (21.4–24.5) 25.0 (23.1–26.9) 23.5 (22.4–24.7) 23.1 (21.5–24.6) 
Bone mineral density (g/cm21.184 (1.140–1.229) 1.141 (1.113–1.169) 1.136 (1.110–1.174) 1.181 (1.138–1.122) 1.146 (1.120–1.172)#### 1.154 (1.120–1.189)#### 
Percent fat-free mass 74.2 (70.0–78.3) 74.3 (71.7–76.9) 73.1 (69.5–76.6) 72.6 (68.0–77.1) 75.3 (72.6–78.1)#### 73.9 (70.3–77.6)## 
Percent total body fat 27.3 (23.0–31.6) 26.8 (24.0–29.5) 27.9 (24.2–31.6) 28.6 (24.0–33.2)# 25.7 (22.9–28.5)## 26.8 (23.0–30.5)## 
Android fat to gynoid fat ratio 0.884 (0.791–0.976) 0.855 (0.797–0.913) 0.827 (0.748–0.906) 0.897 (0.789–1.00) 0.841 (0.776–0.905) 0.844 (0.758–0.931) 

Age and diabetes duration data are means ± SD; other data are means and 95% CIs adjusted for age and sex.

P < 0.05 for comparisons between the two groups with diabetes.

*P < 0.05;

****P < 0.0001 for comparisons with ND Tx.

#P < 0.05;

##P < 0.01;

####P < 0.0001 for a change from baseline within group.

Functional Aerobic Capacity

Overall compliance in the exercise-training groups was high, with an average completion of 84.7% of the total exercise sessions prescribed (84.1% with type 1 diabetes and 85.7% in the group without diabetes), with all participants achieving up to 85% of their VO2peak heart rate during exercise sessions. Table 2 shows the functional aerobic capacity outcomes measured during the maximal oxygen consumption test.

Table 2

Results from VO2peak tests carried out at baseline and after 20 weeks (posttraining) in adolescents with type 1 diabetes who trained (T1D Tx), with type 1 diabetes who did not train (T1D Con), and without diabetes who trained (ND Tx)

TimeBaseline
Posttraining
T1D ConT1D TxND TxT1D ConT1D TxND Tx
N (% female)  15 (53) 38 (47) 22 (5) 13 (46) 37 (49) 22 (55) 
Heart rate (bpm) At rest 76.5 (70.1–82.9)* 74.5 (70.5–78.5)* 67.1 (61.7–72.6) 78.7 (72.1–85.4)** 72.1 (68.1–76.1) 65.9 (60.6–71.3) 
Maximal exercise 182.6 (177.4–187.7) 188.6 (185.4–191.8) 185.7 (181.3–190.1) 181.7 (176.6–186.8) 187.8 (184.7–190.8) 187.4 (183.3–191.5) 
Systolic BP (mmHg) At rest 110.3 (106.3–114.3) 110.2 (107.7–112.7) 106.3 (102.9–109.8) 109.5 (105.4–113.7) 110.2 (107.7–112.7) 106.1 (102.7–109.4) 
Maximal exercise 169.1 (159.7–178.5) 170.2 (164.3–176.1) 160.3 (152.3–168.3) 173.6 (164.9–182.3)** 171.0 (165.7–176.2)* 158.9 (151.9–165.9) 
Diastolic BP (mmHg) At rest 63.3 (59.6–67.0) 63.5 (61.2–65.9) 61.2 (58.0–64.4) 63.3 (59.5–67.1) 63.0 (60.7–65.3) 60.2 (57.1–63.2) 
Maximal exercise 67.5 (63.3–71.7) 67.0 (64.4–69.7) 67.5 (63.9–71.1) 70.6 (66.0–75.3)* 64.9 (62.1–67.7) 64.7 (60.9–68.4) 
Mean arterial pressure (mmHg) At rest 79.0 (75.5–82.4) 79.1 (76.9–81.2) 76.2 (73.2–79.2) 78.7 (75.2–82.3) 78.7 (76.6–80.9) 75.5 (72.6–78.3) 
 Maximal exercise 101.4 (97.0–105.8) 101.4 (98.6–104.2) 98.5 (94.7–102.2) 105.0 (100.6–109.3)**,# 100.3 (97.6–102.9) 96.1 (92.6–99.6) 
O2 pulse Maximal exercise 12.3 (11.0–13.6) 12.3 (11.5–13.2) 12.3 (11.2–13.4) 12.5 (11.0–14.0) 14.0 (13.1–14.9)#### 13.8 (12.6–15.0)#### 
Respiratory exchange ratio Maximal exercise 1.21 (1.18–1.23) 1.20 (1.19–1.22) 1.24 (1.22–1.26) 1.19 (1.15–1.23)* 1.21 (1.19–1.23) 1.25 (1.22–1.27) 
VO2peak (L/min) Maximal exercise 2.19 (2.00–2.38)* 2.24 (2.12–2.36)* 2.47 (2.30–2.63) 2.26 (2.07–2.46)*** 2.51 (2.39–2.64)*,,#### 2.79 (2.63–2.96)#### 
VO2peak (mL/kg FFM/min) Maximal exercise 43.8 (40.4–47.1)* 45.0 (42.9–47.1)* 48.5 (45.7–51.4) 44.2 (40.5–47.8)*** 49.9 (47.7–52.1)*,††,#### 53.6 (50.6–56.5)#### 
Workload (watts) Maximal exercise 190.7 (166.6–214.9) 197.9 (182.7–213.1) 192.1 (171.4–212.8) 187.7 (161.5–214.0) 214.2 (198.4–230.1)#### 218.5 (197.4–239.6)#### 
TimeBaseline
Posttraining
T1D ConT1D TxND TxT1D ConT1D TxND Tx
N (% female)  15 (53) 38 (47) 22 (5) 13 (46) 37 (49) 22 (55) 
Heart rate (bpm) At rest 76.5 (70.1–82.9)* 74.5 (70.5–78.5)* 67.1 (61.7–72.6) 78.7 (72.1–85.4)** 72.1 (68.1–76.1) 65.9 (60.6–71.3) 
Maximal exercise 182.6 (177.4–187.7) 188.6 (185.4–191.8) 185.7 (181.3–190.1) 181.7 (176.6–186.8) 187.8 (184.7–190.8) 187.4 (183.3–191.5) 
Systolic BP (mmHg) At rest 110.3 (106.3–114.3) 110.2 (107.7–112.7) 106.3 (102.9–109.8) 109.5 (105.4–113.7) 110.2 (107.7–112.7) 106.1 (102.7–109.4) 
Maximal exercise 169.1 (159.7–178.5) 170.2 (164.3–176.1) 160.3 (152.3–168.3) 173.6 (164.9–182.3)** 171.0 (165.7–176.2)* 158.9 (151.9–165.9) 
Diastolic BP (mmHg) At rest 63.3 (59.6–67.0) 63.5 (61.2–65.9) 61.2 (58.0–64.4) 63.3 (59.5–67.1) 63.0 (60.7–65.3) 60.2 (57.1–63.2) 
Maximal exercise 67.5 (63.3–71.7) 67.0 (64.4–69.7) 67.5 (63.9–71.1) 70.6 (66.0–75.3)* 64.9 (62.1–67.7) 64.7 (60.9–68.4) 
Mean arterial pressure (mmHg) At rest 79.0 (75.5–82.4) 79.1 (76.9–81.2) 76.2 (73.2–79.2) 78.7 (75.2–82.3) 78.7 (76.6–80.9) 75.5 (72.6–78.3) 
 Maximal exercise 101.4 (97.0–105.8) 101.4 (98.6–104.2) 98.5 (94.7–102.2) 105.0 (100.6–109.3)**,# 100.3 (97.6–102.9) 96.1 (92.6–99.6) 
O2 pulse Maximal exercise 12.3 (11.0–13.6) 12.3 (11.5–13.2) 12.3 (11.2–13.4) 12.5 (11.0–14.0) 14.0 (13.1–14.9)#### 13.8 (12.6–15.0)#### 
Respiratory exchange ratio Maximal exercise 1.21 (1.18–1.23) 1.20 (1.19–1.22) 1.24 (1.22–1.26) 1.19 (1.15–1.23)* 1.21 (1.19–1.23) 1.25 (1.22–1.27) 
VO2peak (L/min) Maximal exercise 2.19 (2.00–2.38)* 2.24 (2.12–2.36)* 2.47 (2.30–2.63) 2.26 (2.07–2.46)*** 2.51 (2.39–2.64)*,,#### 2.79 (2.63–2.96)#### 
VO2peak (mL/kg FFM/min) Maximal exercise 43.8 (40.4–47.1)* 45.0 (42.9–47.1)* 48.5 (45.7–51.4) 44.2 (40.5–47.8)*** 49.9 (47.7–52.1)*,††,#### 53.6 (50.6–56.5)#### 
Workload (watts) Maximal exercise 190.7 (166.6–214.9) 197.9 (182.7–213.1) 192.1 (171.4–212.8) 187.7 (161.5–214.0) 214.2 (198.4–230.1)#### 218.5 (197.4–239.6)#### 

Data are adjusted means and 95% CIs from multivariate models. BP, blood pressure; FFM, fat-free mass.

*P < 0.05;

**P < 0.01;

***P < 0.001 for comparisons with ND Tx.

P < 0.05;

††P < 0.01 for comparisons between the two groups with diabetes.

#P < 0.05;

###P < 0.001;

####P < 0.0001 for a change from baseline within group.

VO2peak expressed by liters per minute adjusted for age, sex, and fat-free mass was lower in the groups with diabetes at baseline. Exercise training increased in exercise capacity in both training groups (12% in the group with type 1 diabetes and 13% in the group without diabetes).

Exercise training did not alter resting and maximal exercise systolic, diastolic, or mean arterial pressure (Table 2). However, the maximal exercise mean arterial pressure increased in the control group with type 1 diabetes after 20 weeks. Exercise training improved maximal O2 pulse and workload achieved on both training groups. Resting heart rate was comparatively higher at baseline on both groups with type 1 diabetes compared with adolescents without diabetes; this parameter remained higher in the control group with type 1 diabetes, but not in the training group with type 1 diabetes after 20 weeks.

Left Ventricular Function During MRI Scanning

Table 3 shows the MRI scan outcomes for left ventricular function at rest and during supine submaximal exercise, both at baseline and posttraining.

Table 3

Cardiac MRI parameters at rest and during submaximal exercise at baseline and after 20 weeks (posttraining) in adolescents with type 1 diabetes who trained (T1D Tx), with type 1 diabetes who did not train (T1D Con), and without diabetes who trained (ND Tx)

TimeBaseline
Posttraining
T1D ConT1D TxND TxT1D ConT1D TxND Tx
N (% female)  15 (53) 38 (47) 22 (55) 13 (46) 37 (49) 22 (55) 
Left ventricular mass (g) At rest 129.5 ± 4.8 128.4 ± 3.1 133.7 ± 4.3 130.8 ± 5.2 131.6 ± 3.2### 141.7 ± 4.4#### 
Left ventricular mass (g/kg FFM)  2.59 (2.39–2.78) 2.58 (2.45–2.70) 2.72 (2.55–2.88) 2.58 (2.39–2.77) 2.60 (2.49–2.71) 2.77 (2.62–2.92) 
Heart rate (bpm) At rest 72.9 (67.4–78.5) 75.2 (71.7–78.7) 70.1 (65.3–74.8) 73.7 (67.6–79.8) 69.8 (66.2–73.5)## 65.0 (60.1–69.8)# 
Submaximal exercise 109.4 (106.6–112.3) 109.8 (108.0–111.6) 108.9 (106.5–111.4) 108.3 (106.0–110.6) 108.2 (106.8–109.6)## 107.9 (106.0–109.7) 
Systolic blood pressure (mmHg) At rest 108.2 (103.0–113.3) 110.4 (107.1–113.6)** 102.7 (98.3–107.1) 109.6 (104.4–114.8) 107.9 (104.7–111.0) 102.9 (98.7–107.1) 
Submaximal exercise 128.2 (119.8–136.6) 128.2 (123.0–133.5) 119.3 (112.1–126.5) 123.5 (115.8–131.1) 123.0 (118.4–127.6)# 119.3 (113.2–125.4) 
Diastolic blood pressure (mmHg) At rest 60.3 (56.2–64.5) 60.7 (58.1–63.3)* 56.0 (52.4–59.5) 60.8 (56.7–64.8) 56.4 (53.9–58.8)## 58.0 (54.8–61.3) 
Submaximal exercise 66.2 (60.8–71.5) 65.9 (62.6–69.3) 60.7 (56.2–65.3) 66.1 (61.4–70.8) 64.7 (61.9–67.5) 60.8 (57.0–64.5) 
Mean arterial pressure (mmHg) At rest 76.3 (72.7–79.9)* 77.2 (75.0–79.5)** 71.5 (68.5–74.6) 77.0 (73.5–80.6) 73.5 (71.4–75.7)## 73.0 (70.1–75.8) 
Submaximal exercise 86.8 (81.4–92.2) 86.7 (83.3–90.1) 80.3 (75.6–84.9) 85.2 (80.5–89.9) 84.1 (81.3–86.9) 80.3 (76.5–54.1) 
Cardiac output (L/min) At rest 6.66 (6.04–7.27) 7.00 (6.61–7.39) 6.67 (6.13–7.22) 6.62 (5.87–7.36) 7.02 (6.56–7.48) 6.65 (6.03–7.27) 
Submaximal exercise 10.25 (9.49–11.00)* 10.30 (9.82–10.79)** 11.45 (10.78–12.12) 10.03 (9.08–10.98)*** 11.40 (10.81–11.99)*,,#### 12.56 (11.76–13.35)## 
Cardiac output (mL/kg FFM) At rest 133.5 (118.8–146.3) 141.0 (132.3–149.6) 142.3 (130.6–154.1) 130.4 (116.0–144.7) 137.9 (129.2–146.5) 134.8 (123.3–146.3) 
Submaximal exercise 206.5 (190.8–222.1)** 207.7 (197.8–217.5)** 235.9 (222.5–249.3) 198.2 (180.4–216)**** 225.8 (215.1–236.6)**,††,### 252.4 (238.0–266.7)## 
Stroke volume (mL) At rest 91.9 (84.7–99.1) 92.9 (88.3–97.5) 96.3 (89.9–102.7) 91.2 (82.4–99.9)* 100.5 (95.1–105.9)#### 104.9 (97.6–112.2)## 
Submaximal exercise 93.9 (87.1–100.7)* 93.7 (89.4–98.0)** 105.9 (99.9–111.9) 92.8 (84.0–101.6)*** 105.5 (100.1 –110.9)*,,#### 116.7 (109.3–124.0)## 
Stroke volume (mL/kg FFM) At rest 1.82 (1.67–1.98)* 1.87 (1.77–1.97)* 2.05 (1.92–2.19) 1.80 (1.64–1.96)** 1.98 (1.89–2.08)*,### 2.08 (1.95–2.21) 
Submaximal exercise 1.89 (1.76–2.03)** 1.90 (1.82–1.99)*** 2.17 (2.05–2.28) 1.83 (1.67–1.99)**** 2.09 (1.99–2.19)**,††,#### 2.34 (2.21–2.47)### 
End-diastolic volume (mL) At rest 143 (133–153) 147 (141–154) 157 (148–166) 150 (138–162) 150 (143–157)# 163 (153–173)# 
Submaximal exercise 135 (126–145)* 139 (133–145)* 153 (144–161) 138 (126–149)** 147 (140–154)*,## 161 (151–171)# 
End-diastolic volume (mL/kg FFM) At rest 2.88 (2.67–3.08)* 2.96 (2.84–3.09)* 3.20 (3.03–3.38) 2.97 (2.75–3.18) 2.98 (2.85–3.11)* 3.21 (3.04–3.39) 
Submaximal exercise 2.73 (2.54–2.92)** 2.81 (2.69–2.93)** 3.09 (2.93–3.25) 2.72 (2.51–2.92)*** 2.93 (2.81–3.05)*,# 3.18 (3.02–3.34) 
End-systolic volume (mL) At rest 51.5 (46.3–56.6)* 54.3 (51.0–57.6)* 60.4 (55.9–65.0) 55.7 (49.7–61.8)# 50.2 (46.5–54.0)* 58.0 (53.0–63.0) 
Submaximal exercise 41.2 (35.6–46.7) 45.2 (41.7–48.8) 46.5 (41.6–51.4) 44.2 (38.6–49.7) 40.1 (36.6–43.6)# 43.6 (39.0–48.3) 
End-systolic volume (mL/kg FFM) At rest 1.04 (0.94–1.14)* 1.09 (1.03–1.16)* 1.21 (1.12–1.30) 1.11 (0.99–1.23) 1.00 (0.93–1.07)*,## 1.13 (1.04–1.23)# 
Submaximal exercise 0.83 (0.72–0.94) 0.92 (0.85–0.98) 0.91 (0.82–1.01) 0.88 (0.76–0.99) 0.81 (0.74–0.87)## 0.85 (0.76–0.94)## 
Ejection fraction (%) At rest 64.4 (61.9–66.9) 63.0 (61.4–64.5) 62.8 (60.6–64.9) 61.8 (59.2–64.4)## 66.3 (64.8–67.9)††,### 64.7 (62.6–66.8) 
Submaximal exercise 69.4 (64.7–74.1) 66.1 (63.2–69.1) 69.9 (65.9–73.9) 67.5 (64.7–70.4)**,# 72.1 (70.4–73.8)††,#### 73.4 (71.1–75.6)### 
Stroke work At rest 95.2 (86.4–104.0) 97.6 (92.0–103.3) 94.4 (86.6–102.2) 95.5 (84.5–106.5) 101.0 (94.2–107.8) 104.6 (95.5–113.8)## 
Submaximal exercise 111.5 (99.4–123.5) 110.5 (102.8–118.2) 118.8 (108.2–129.4) 108.1 (96.4–119.9)* 120.5 (113.2–127.7)## 128.5 (118.7–138.3)# 
Total peripheral resistance At rest 11.9 (10.7–13.0) 11.5 (10.7–12.2) 11.0 (10.0–12.0) 12.1 (11.0–13.1) 11.1 (10.4–11.7) 11.4 (10.5–12.3) 
Submaximal exercise 8.5 (7.8–9.4)* 8.7 (8.2–9.2)** 7.2 (6.5–7.9) 8.8 (8.0–9.5)**** 7.6 (7.2–8.1)*,,#### 6.6 (5.9–7.2) 
Workload (watts) Submaximal exercise 37.7 (30.7–44.7) 35.4 (31.2–39.6) 34.9 (28.7–41.1) 32.5 (25.0–40.1)* 41.5 (37.1–45.8)**,,# 49.0 (42.8–55.2)#### 
TimeBaseline
Posttraining
T1D ConT1D TxND TxT1D ConT1D TxND Tx
N (% female)  15 (53) 38 (47) 22 (55) 13 (46) 37 (49) 22 (55) 
Left ventricular mass (g) At rest 129.5 ± 4.8 128.4 ± 3.1 133.7 ± 4.3 130.8 ± 5.2 131.6 ± 3.2### 141.7 ± 4.4#### 
Left ventricular mass (g/kg FFM)  2.59 (2.39–2.78) 2.58 (2.45–2.70) 2.72 (2.55–2.88) 2.58 (2.39–2.77) 2.60 (2.49–2.71) 2.77 (2.62–2.92) 
Heart rate (bpm) At rest 72.9 (67.4–78.5) 75.2 (71.7–78.7) 70.1 (65.3–74.8) 73.7 (67.6–79.8) 69.8 (66.2–73.5)## 65.0 (60.1–69.8)# 
Submaximal exercise 109.4 (106.6–112.3) 109.8 (108.0–111.6) 108.9 (106.5–111.4) 108.3 (106.0–110.6) 108.2 (106.8–109.6)## 107.9 (106.0–109.7) 
Systolic blood pressure (mmHg) At rest 108.2 (103.0–113.3) 110.4 (107.1–113.6)** 102.7 (98.3–107.1) 109.6 (104.4–114.8) 107.9 (104.7–111.0) 102.9 (98.7–107.1) 
Submaximal exercise 128.2 (119.8–136.6) 128.2 (123.0–133.5) 119.3 (112.1–126.5) 123.5 (115.8–131.1) 123.0 (118.4–127.6)# 119.3 (113.2–125.4) 
Diastolic blood pressure (mmHg) At rest 60.3 (56.2–64.5) 60.7 (58.1–63.3)* 56.0 (52.4–59.5) 60.8 (56.7–64.8) 56.4 (53.9–58.8)## 58.0 (54.8–61.3) 
Submaximal exercise 66.2 (60.8–71.5) 65.9 (62.6–69.3) 60.7 (56.2–65.3) 66.1 (61.4–70.8) 64.7 (61.9–67.5) 60.8 (57.0–64.5) 
Mean arterial pressure (mmHg) At rest 76.3 (72.7–79.9)* 77.2 (75.0–79.5)** 71.5 (68.5–74.6) 77.0 (73.5–80.6) 73.5 (71.4–75.7)## 73.0 (70.1–75.8) 
Submaximal exercise 86.8 (81.4–92.2) 86.7 (83.3–90.1) 80.3 (75.6–84.9) 85.2 (80.5–89.9) 84.1 (81.3–86.9) 80.3 (76.5–54.1) 
Cardiac output (L/min) At rest 6.66 (6.04–7.27) 7.00 (6.61–7.39) 6.67 (6.13–7.22) 6.62 (5.87–7.36) 7.02 (6.56–7.48) 6.65 (6.03–7.27) 
Submaximal exercise 10.25 (9.49–11.00)* 10.30 (9.82–10.79)** 11.45 (10.78–12.12) 10.03 (9.08–10.98)*** 11.40 (10.81–11.99)*,,#### 12.56 (11.76–13.35)## 
Cardiac output (mL/kg FFM) At rest 133.5 (118.8–146.3) 141.0 (132.3–149.6) 142.3 (130.6–154.1) 130.4 (116.0–144.7) 137.9 (129.2–146.5) 134.8 (123.3–146.3) 
Submaximal exercise 206.5 (190.8–222.1)** 207.7 (197.8–217.5)** 235.9 (222.5–249.3) 198.2 (180.4–216)**** 225.8 (215.1–236.6)**,††,### 252.4 (238.0–266.7)## 
Stroke volume (mL) At rest 91.9 (84.7–99.1) 92.9 (88.3–97.5) 96.3 (89.9–102.7) 91.2 (82.4–99.9)* 100.5 (95.1–105.9)#### 104.9 (97.6–112.2)## 
Submaximal exercise 93.9 (87.1–100.7)* 93.7 (89.4–98.0)** 105.9 (99.9–111.9) 92.8 (84.0–101.6)*** 105.5 (100.1 –110.9)*,,#### 116.7 (109.3–124.0)## 
Stroke volume (mL/kg FFM) At rest 1.82 (1.67–1.98)* 1.87 (1.77–1.97)* 2.05 (1.92–2.19) 1.80 (1.64–1.96)** 1.98 (1.89–2.08)*,### 2.08 (1.95–2.21) 
Submaximal exercise 1.89 (1.76–2.03)** 1.90 (1.82–1.99)*** 2.17 (2.05–2.28) 1.83 (1.67–1.99)**** 2.09 (1.99–2.19)**,††,#### 2.34 (2.21–2.47)### 
End-diastolic volume (mL) At rest 143 (133–153) 147 (141–154) 157 (148–166) 150 (138–162) 150 (143–157)# 163 (153–173)# 
Submaximal exercise 135 (126–145)* 139 (133–145)* 153 (144–161) 138 (126–149)** 147 (140–154)*,## 161 (151–171)# 
End-diastolic volume (mL/kg FFM) At rest 2.88 (2.67–3.08)* 2.96 (2.84–3.09)* 3.20 (3.03–3.38) 2.97 (2.75–3.18) 2.98 (2.85–3.11)* 3.21 (3.04–3.39) 
Submaximal exercise 2.73 (2.54–2.92)** 2.81 (2.69–2.93)** 3.09 (2.93–3.25) 2.72 (2.51–2.92)*** 2.93 (2.81–3.05)*,# 3.18 (3.02–3.34) 
End-systolic volume (mL) At rest 51.5 (46.3–56.6)* 54.3 (51.0–57.6)* 60.4 (55.9–65.0) 55.7 (49.7–61.8)# 50.2 (46.5–54.0)* 58.0 (53.0–63.0) 
Submaximal exercise 41.2 (35.6–46.7) 45.2 (41.7–48.8) 46.5 (41.6–51.4) 44.2 (38.6–49.7) 40.1 (36.6–43.6)# 43.6 (39.0–48.3) 
End-systolic volume (mL/kg FFM) At rest 1.04 (0.94–1.14)* 1.09 (1.03–1.16)* 1.21 (1.12–1.30) 1.11 (0.99–1.23) 1.00 (0.93–1.07)*,## 1.13 (1.04–1.23)# 
Submaximal exercise 0.83 (0.72–0.94) 0.92 (0.85–0.98) 0.91 (0.82–1.01) 0.88 (0.76–0.99) 0.81 (0.74–0.87)## 0.85 (0.76–0.94)## 
Ejection fraction (%) At rest 64.4 (61.9–66.9) 63.0 (61.4–64.5) 62.8 (60.6–64.9) 61.8 (59.2–64.4)## 66.3 (64.8–67.9)††,### 64.7 (62.6–66.8) 
Submaximal exercise 69.4 (64.7–74.1) 66.1 (63.2–69.1) 69.9 (65.9–73.9) 67.5 (64.7–70.4)**,# 72.1 (70.4–73.8)††,#### 73.4 (71.1–75.6)### 
Stroke work At rest 95.2 (86.4–104.0) 97.6 (92.0–103.3) 94.4 (86.6–102.2) 95.5 (84.5–106.5) 101.0 (94.2–107.8) 104.6 (95.5–113.8)## 
Submaximal exercise 111.5 (99.4–123.5) 110.5 (102.8–118.2) 118.8 (108.2–129.4) 108.1 (96.4–119.9)* 120.5 (113.2–127.7)## 128.5 (118.7–138.3)# 
Total peripheral resistance At rest 11.9 (10.7–13.0) 11.5 (10.7–12.2) 11.0 (10.0–12.0) 12.1 (11.0–13.1) 11.1 (10.4–11.7) 11.4 (10.5–12.3) 
Submaximal exercise 8.5 (7.8–9.4)* 8.7 (8.2–9.2)** 7.2 (6.5–7.9) 8.8 (8.0–9.5)**** 7.6 (7.2–8.1)*,,#### 6.6 (5.9–7.2) 
Workload (watts) Submaximal exercise 37.7 (30.7–44.7) 35.4 (31.2–39.6) 34.9 (28.7–41.1) 32.5 (25.0–40.1)* 41.5 (37.1–45.8)**,,# 49.0 (42.8–55.2)#### 

Data are means and 95% CIs adjusted for age and sex.

FFM, fat-free mass.

*P < 0.05;

**P < 0.01;

***P < 0.001;

****P < 0.0001 for comparisons with ND Tx.

P < 0.05;

††P < 0.01 for comparisons between the two groups with diabetes.

#P < 0.05;

##P < 0.01;

###P < 0.001;

####P < 0.0001 for a change from baseline within group.

Heart Rate, Blood Pressure, and Mean Arterial Pressure

After training, there was a significant reduction in the resting heart rate in both training groups (Table 3). Resting mean arterial pressure, submaximal exercise systolic blood pressure, and resting diastolic blood pressure decreased in the training group with type 1 diabetes after 20 weeks of exercise.

Left Ventricular Function (Resting)

The exercise intervention significantly improved the left ventricular function of both training groups at rest (Table 3). There was an increase in stroke volume and a decrease in heart rate in the supine position, with no changes in cardiac output. The increase in stroke volume was attributed to changes in left ventricular filling capacity, as shown by larger end-diastolic volume in training groups. There was no change in end-systolic volume observed in those with diabetes who exercise trained in contrast to an increase observed in the adolescents with diabetes who did not train. In agreement with these findings, resting ejection fraction increased in adolescents with diabetes who trained, but decreased in those who did not.

Left Ventricular Function (Submaximal Exercise)

Submaximal exercise cardiac output, stroke volume, end-diastolic volume, and ejection fraction increased significantly in the two training groups (Table 3). The training group without diabetes and, to a lesser extent, the training group with type 1 diabetes required an increased workload to maintain their target heart rate during the submaximal exercise MRI scan. Interestingly, the training group with type 1 diabetes also showed improvement in contractility with a significant decrease in end-systolic volume after the intervention that was not observed in the training group without diabetes. Table 3 also illustrates the left ventricular volumes indexed for participants’ fat-free mass. Twenty weeks of exercise training improved indexed cardiac output, stroke volume, and end-diastolic volume during exercise in the group with diabetes.

Left Ventricular Outcomes as Percentage Change

To gain a better understanding of the alterations that occurred in the left ventricular function, we calculated the percentage change of cardiac output, stroke volume, end-diastolic volume, end-systolic volume, and ejection fraction from rest to submaximal exercise at baseline and after 20 weeks of training (Fig. 1). There were improvements in both training groups, but greater improvements overall were observed in those with diabetes.

Figure 1

Percentage changes in cardiac outcomes from rest to exercise at baseline and after 20 weeks (posttraining) in adolescents with type 1 diabetes who trained (T1D Tx), with type 1 diabetes who did not train (T1D Con), and without diabetes who trained (ND Tx). *P < 0.05; **P < 0.01 for comparisons with ND Tx; †P < 0.05 for comparisons between the two groups with diabetes; #P < 0.05; ##P < 0.01; ###P < 0.001 for differences from baseline within groups.

Figure 1

Percentage changes in cardiac outcomes from rest to exercise at baseline and after 20 weeks (posttraining) in adolescents with type 1 diabetes who trained (T1D Tx), with type 1 diabetes who did not train (T1D Con), and without diabetes who trained (ND Tx). *P < 0.05; **P < 0.01 for comparisons with ND Tx; †P < 0.05 for comparisons between the two groups with diabetes; #P < 0.05; ##P < 0.01; ###P < 0.001 for differences from baseline within groups.

Close modal

Total Peripheral Resistance

Total peripheral resistance at rest did not alter with training intervention (Table 3). The total peripheral resistance during submaximal exercise, however, was higher in the groups with diabetes prior to the intervention and significantly reduced in the training group with type 1 diabetes. Although total peripheral resistance improved in the training group with type 1 diabetes, it remained elevated compared with the training group without diabetes.

Training and Glycemic Control

There were no associations between glycemic control (HbA1c) and diabetes duration with the MRI variables posttraining. However, higher HbA1c levels were associated with worse functional aerobic capacity outcomes including higher resting heart rate (P = 0.007 for the control group with type 1 diabetes and P = 0.003 for the training group with type 1 diabetes), higher resting diastolic blood pressure (P = 0.031), and higher resting mean arterial pressure (P = 0.035) overall. Glycemic control was also inversely associated with VO2peak in both groups with diabetes (P = 0.029 for the control group with type 1 diabetes and P = 0.009 for the training group with type 1 diabetes).

To our knowledge, this is the first study to investigate the effects of exercise training on the cardiac performance at rest and during exercise in adolescents with type 1 diabetes using exercise MRI. This study confirms that aerobic capacity is reduced in these adolescents and that this, at least in part, can be attributed to impaired left ventricular function and a blunted cardiac response to exercise (9). Importantly, although an aerobic exercise-training program improved the aerobic capacity and cardiac function in adolescents with type 1 diabetes, it did not normalize them to the levels seen in the training group without diabetes. Both left ventricular filling and contractility improved after exercise training in adolescents with diabetes, suggesting that aerobic fitness may prevent or delay the well-described impairment in left ventricular function in diabetes (9,10).

The increase in peak aerobic capacity (∼12%) seen in this study was consistent with previous exercise interventions in adults and adolescents with diabetes (14). However, the baseline peak aerobic capacity was lower in the participants with diabetes and improved with training to a level similar to the baseline observed in the participants without diabetes; therefore, trained adolescents with diabetes remained less fit than equally trained adolescents without diabetes. This suggests there are persistent differences in the cardiovascular function in adolescents with diabetes that are not overcome by exercise training. Consistent with our findings, studies in rodents showed that training-induced increases in cardiac output, stroke volume, and end-diastolic volume in diabetic animals have only reached values equivalent to untrained nondiabetic rodents (15). Thus, although there is some reversibility in cardiac function with exercise training, these adaptations do not achieve levels found in healthy adolescents without diabetes.

A novel observation from this study was that regular exercise reverses the diastolic effects of type 1 diabetes. Left ventricular filling patterns (16) and end-diastolic volume (10) are reduced in adolescents with well-controlled type 1 diabetes. Although we did not quantify filling patterns, we found that exercise training increased end-diastolic volume and stroke volume to levels found in healthy untrained adolescents without diabetes both at rest and during moderate-intensity exercise. Supine exercise exposes the heart to elevated left ventricular preload and large end-diastolic volume (6); therefore, increasing end-diastolic volume under these conditions requires greater left ventricular compliance, increased left ventricular filling pressure, or both (17). We did not measure left ventricular pressure, but others have shown that left ventricular compliance increases after endurance training and is reduced by inactivity (18). Thus, it is possible that the improvements in end-diastolic volume in the trained group with diabetes were because of improved left ventricular compliance.

Blood volume was not measured in this study, but a training-induced increase in blood volume may have influenced our findings. Blood volume increases with chronic exercise training (19), and endurance-trained athletes rely on increased total blood volume and increased rates of diastolic filling to achieve greater stroke volume during exercise (20,21). Type 1 (22) and type 2 diabetes (23) are associated with reduced blood volume and smaller end-diastolic volume. Thus, a preload reduction caused by a smaller blood volume in adolescents with diabetes may have contributed to lower end-diastolic volume and stroke volume at baseline, whereas training-induced plasma volume expansion may have combined with changes in left ventricular relaxation to increase end-diastolic volume and stroke volume after 5 months of exercise training.

The improved ejection fraction seen with training in our adolescent population agrees with previous studies in healthy individuals (24). However, unlike adults, in whom changes in end-diastolic volume underlie improved ejection fraction (25), the adolescents with type 1 diabetes in this study appeared to rely more on reductions in end-systolic volume to increase stroke volume and ejection fraction after training (24). Indeed, the reductions in resting end-systolic volume and ejection fraction, without changes in total peripheral resistance or arterial blood pressure, are consistent with increased resting contractility.

We note that although the control with diabetes in our cohort was not within the International Society for Pediatric and Adolescent Diabetes guidelines (HbA1c <7.5%), they were in a range consistent with glycemic control in adolescents internationally. The DCCT trial indicated that among intensively treated adolescents, the average HbA1c was 8.1%, and this changed little over time (26). A large cohort of 27,035 with type 1 diabetes in Austria in 2008 showed a mean HbA1c of 8.0% between 12 and 16 years of age (27). Similarly, a study of patients on insulin pumps and continuous glucose monitoring showed mean HbA1c levels between 8.0 and 8.2% among adolescents (28). The SWEET registry of multiple European sites in 2016 demonstrated a mean HbA1c of 8.2% for patients on multiple daily injections (interquartile range 7.3–9.4%) in children aged 12–18 years (29). Thus, the range of HbA1c levels in this group is similar to those reported internationally. Although we accept that this is not an ideal glycemic control, it is extremely difficult to achieve better control in adolescents. There were no associations between glycemic control and cardiac function (at baseline or during exercise) in the current study, although glycemic control was inversely associated with aerobic capacity in the adolescent cohort. Similarly, data on adult elite athletes with diabetes indicated that better glycemic control resulted in improved cardiovascular performance (12). Specifically, Baldi and Hofman (12) showed that athletes with diabetes were able to achieve a similar cardiopulmonary response as those without diabetes, but this response was reduced by poor glycemic control. Thus, our data cannot be extrapolated to patients with good glycemic control. In addition, Niranjan et al. (30) showed in a small 7-year follow-up study in nonathlete adults with diabetes that those with higher HbA1c had decreased exercise capacity, maximal heart rate, and cardiac and stroke indices.

Although regular exercise potentially could improve HbA1c, the majority of studies have failed to show this (3134). Exercise training improved aerobic capacity in this study without affecting glucose control in the participants with diabetes, suggesting that the effects of glycemic status and exercise training may work independently to improve aerobic capacity. Nadeau et al. (35) have recently shown that insulin resistance may independently decrease exercise capacity in nonobese youth with type 1 diabetes, being a stronger correlate than HbA1c. We did not directly measure insulin resistance in our study, but insulin dose decreased by ∼10% after training, an indirect measure of insulin sensitivity.

It is important to note that our study has a few limitations. Our sample size was relatively small. However, to our knowledge, this is the largest study ever performed using MRI scans to examine the effects of exercise on cardiac function in subjects with diabetes. There were also a large number of pairwise statistical comparisons carried out without adjustment for multiple comparisons. This is a potential limitation that would have inflated the likelihood of type 1 errors. Thus, our findings need to be interpreted accordingly. The age difference between groups (mean difference of 1 year) could have contributed to the baseline differences seen in the study, although this is unlikely, as the cardiac parameters were controlled for age during analysis. Moreover, previous studies have shown that aerobic capacity does not substantively change with age in adolescence, and, when adjusted for body weight, it actually declines slightly (36). The participants in this study also had HbA1c levels above the recommended limits (<7.5%); therefore, interpretation of our findings cannot be extended to well-controlled youth with diabetes.

In summary, regular intense exercise over 20 weeks was associated with clinically relevant improvements in aerobic capacity and improved left ventricular function. However, in trained adolescents with diabetes, these improvements only achieved levels similar to untrained control subjects without diabetes. In trained adolescents with type 1 diabetes, increased stroke volume was achieved by both increased end-diastolic volume and reduced end-systolic volume, consistent with improved filling and increased left ventricular contractility after training. Given the potential to prevent or reverse the progressive diastolic abnormalities that occur in diabetes, our data support regular intense exercise in adolescents with diabetes.

Clinical trial reg. no. ACTRN12608000075381, www.anzctr.org.au.

Acknowledgments. The authors thank all of the participants and families for involvement and support throughout the study and Janene Biggs (Liggins Institute) and the Center for Advanced MRI staff at the University of Auckland for assistance with the study.

Funding. This work was supported in part by grants from the Australasian Paediatric Endocrine Group and the Maurice and Phyllis Paykel Trust.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. S.G., J.C.B., W.S.C., and P.L.H. conceived and designed the study. S.G. coordinated the trial and supervised training sessions. S.G. and T.P. performed the assessments. S.G., T.P., and T.H. researched data. S.G. and J.G.B.D. carried out statistical analysis. S.G., J.C.B., J.G.B.D., and P.L.H. wrote the manuscript with input from all of the other authors. P.L.H. is the guarantor of this work and, as such, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

1.
Warburton
DE
,
Nicol
CW
,
Bredin
SS
.
Health benefits of physical activity: the evidence
.
CMAJ
2006
;
174
:
801
809
[PubMed]
2.
Blomqvist
CG
,
Saltin
B
.
Cardiovascular adaptations to physical training
.
Annu Rev Physiol
1983
;
45
:
169
189
[PubMed]
3.
Spina
RJ
,
Ogawa
T
,
Kohrt
WM
,
Martin
WH
 3rd
,
Holloszy
JO
,
Ehsani
AA
.
Differences in cardiovascular adaptations to endurance exercise training between older men and women
.
J Appl Physiol (1985)
1993
;
75
:
849
855
[PubMed]
4.
Spina
RJ
,
Ogawa
T
,
Martin
WH
 3rd
,
Coggan
AR
,
Holloszy
JO
,
Ehsani
AA
.
Exercise training prevents decline in stroke volume during exercise in young healthy subjects
.
J Appl Physiol (1985)
1992
;
72
:
2458
2462
[PubMed]
5.
Rodrigues
AC
,
de Melo Costa
J
,
Alves
GB
, et al
.
Left ventricular function after exercise training in young men
.
Am J Cardiol
2006
;
97
:
1089
1092
[PubMed]
6.
Poliner
LR
,
Dehmer
GJ
,
Lewis
SE
,
Parkey
RW
,
Blomqvist
CG
,
Willerson
JT
.
Left ventricular performance in normal subjects: a comparison of the responses to exercise in the upright and supine positions
.
Circulation
1980
;
62
:
528
534
[PubMed]
7.
Vogelsang
TW
,
Hanel
B
,
Kristoffersen
US
, et al
.
Effect of eight weeks of endurance exercise training on right and left ventricular volume and mass in untrained obese subjects: a longitudinal MRI study
.
Scand J Med Sci Sports
2008
;
18
:
354
359
[PubMed]
8.
Karlefors
T
.
Haemodynamic studies in male diabetics
.
Acta Med Scand Suppl
1966
;
449
:
45
80
[PubMed]
9.
Gusso
S
,
Hofman
P
,
Lalande
S
,
Cutfield
W
,
Robinson
E
,
Baldi
JC
.
Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus
.
Diabetologia
2008
;
51
:
1317
1320
[PubMed]
10.
Gusso
S
,
Pinto
TE
,
Baldi
JC
,
Robinson
E
,
Cutfield
WS
,
Hofman
PL
.
Diastolic function is reduced in adolescents with type 1 diabetes in response to exercise
.
Diabetes Care
2012
;
35
:
2089
2094
[PubMed]
11.
Fang
ZY
,
Prins
JB
,
Marwick
TH
.
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications
.
Endocr Rev
2004
;
25
:
543
567
[PubMed]
12.
Baldi
JC
,
Hofman
PL
.
Does careful glycemic control improve aerobic capacity in subjects with type 1 diabetes?
Exerc Sport Sci Rev
2010
;
38
:
161
167
[PubMed]
13.
Gusso
S
,
Salvador
C
,
Hofman
P
, et al
.
Design and testing of an MRI-compatible cycle ergometer for non-invasive cardiac assessments during exercise
.
Biomed Eng Online
2012
;
11
:
13
[PubMed]
14.
Yardley
JE
,
Hay
J
,
Abou-Setta
AM
,
Marks
SD
,
McGavock
J
.
A systematic review and meta-analysis of exercise interventions in adults with type 1 diabetes
.
Diabetes Res Clin Pract
2014
;
106
:
393
400
[PubMed]
15.
Loganathan
R
,
Bilgen
M
,
Al-Hafez
B
,
Zhero
SV
,
Alenezy
MD
,
Smirnova
IV
.
Exercise training improves cardiac performance in diabetes: in vivo demonstration with quantitative cine-MRI analyses
.
J Appl Physiol (1985)
2007
;
102
:
665
672
[PubMed]
16.
Suys
BE
,
Katier
N
,
Rooman
RP
, et al
.
Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy
.
Diabetes Care
2004
;
27
:
1947
1953
[PubMed]
17.
Patterson
SW
,
Starling
EH
.
On the mechanical factors which determine the output of the ventricles
.
J Physiol
1914
;
48
:
357
379
[PubMed]
18.
Arbab-Zadeh
A
,
Dijk
E
,
Prasad
A
, et al
.
Effect of aging and physical activity on left ventricular compliance
.
Circulation
2004
;
110
:
1799
1805
[PubMed]
19.
Convertino
VA
.
Blood volume: its adaptation to endurance training
.
Med Sci Sports Exerc
1991
;
23
:
1338
1348
[PubMed]
20.
Krip
B
,
Gledhill
N
,
Jamnik
V
,
Warburton
D
.
Effect of alterations in blood volume on cardiac function during maximal exercise
.
Med Sci Sports Exerc
1997
;
29
:
1469
1476
[PubMed]
21.
Gledhill
N
,
Cox
D
,
Jamnik
R
.
Endurance athletes’ stroke volume does not plateau: major advantage is diastolic function
.
Med Sci Sports Exerc
1994
;
26
:
1116
1121
[PubMed]
22.
Rissanen
AP
,
Tikkanen
HO
,
Koponen
AS
,
Aho
JM
,
Peltonen
JE
.
Central and peripheral cardiovascular impairments limit VO(2peak) in type 1 diabetes
.
Med Sci Sports Exerc
2015
;
47
:
223
230
[PubMed]
23.
Lalande
S
,
Hofman
PL
,
Baldi
JC
.
Effect of reduced total blood volume on left ventricular volumes and kinetics in type 2 diabetes
.
Acta Physiol (Oxf)
2010
;
199
:
23
30
[PubMed]
24.
Oyen
EM
,
Schuster
S
,
Brode
PE
.
Dynamic exercise echocardiography of the left ventricle in physically trained children compared to untrained healthy children
.
Int J Cardiol
1990
;
29
:
29
33
[PubMed]
25.
Vanoverschelde
JJ
,
Essamri
B
,
Vanbutsele
R
, et al
.
Contribution of left ventricular diastolic function to exercise capacity in normal subjects
.
J Appl Physiol (1985)
1993
;
74
:
2225
2233
[PubMed]
26.
Diabetes Control and Complications Trial Research Group
.
Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial
.
J Pediatr
1994
;
125
:
177
188
[PubMed]
27.
Gerstl
EM
,
Rabl
W
,
Rosenbauer
J
, et al
.
Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade
.
Eur J Pediatr
2008
;
167
:
447
453
[PubMed]
28.
Hirsch
IB
,
Abelseth
J
,
Bode
BW
, et al
.
Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study
.
Diabetes Technol Ther
2008
;
10
:
377
383
[PubMed]
29.
Szypowska
A
,
Schwandt
A
,
Svensson
J
, et al.;
SWEET Study Group
.
Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry
.
Pediatr Diabetes
2016
;
17
(
Suppl. 23
):
38
45
[PubMed]
30.
Niranjan
V
,
McBrayer
DG
,
Ramirez
LC
,
Raskin
P
,
Hsia
CC
.
Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus
.
Am J Med
1997
;
103
:
504
513
[PubMed]
31.
Stratton
R
,
Wilson
DP
,
Endres
RK
,
Goldstein
DE
.
Improved glycemic control after supervised 8-wk exercise program in insulin-dependent diabetic adolescents
.
Diabetes Care
1987
;
10
:
589
593
[PubMed]
32.
Mosher
PE
,
Nash
MS
,
Perry
AC
,
LaPerriere
AR
,
Goldberg
RB
.
Aerobic circuit exercise training: effect on adolescents with well-controlled insulin-dependent diabetes mellitus
.
Arch Phys Med Rehabil
1998
;
79
:
652
657
[PubMed]
33.
Ramalho
AC
,
de Lourdes Lima
M
,
Nunes
F
, et al
.
The effect of resistance versus aerobic training on metabolic control in patients with type-1 diabetes mellitus
.
Diabetes Res Clin Pract
2006
;
72
:
271
276
[PubMed]
34.
Marrero
DG
,
Fremion
AS
,
Golden
MP
.
Improving compliance with exercise in adolescents with insulin-dependent diabetes mellitus: results of a self-motivated home exercise program
.
Pediatrics
1988
;
81
:
519
525
[PubMed]
35.
Nadeau
KJ
,
Regensteiner
JG
,
Bauer
TA
, et al
.
Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function
.
J Clin Endocrinol Metab
2010
;
95
:
513
521
[PubMed]
36.
Kemper
HC
,
Twisk
JW
,
van Mechelen
W
.
Changes in aerobic fitness in boys and girls over a period of 25 years: data from the Amsterdam Growth And Health Longitudinal Study revisited and extended
.
Pediatr Exerc Sci
2013
;
25
:
524
535
[PubMed]
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.